ReviewPharmaceuticals (Basel, Switzerland)2021

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.

Surachet Imlimthan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.